Immunostimulants and prevention of recurrent respiratory respiratory tract infections

Susanna Esposito, A. Musio

Research output: Contribution to journalArticle

Abstract

Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for pediatricians. They affect the children's quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have been developed. One of the most widely used is the administration of immunostimulants: i.e. molecules of bacterial or synthetic origin that interact with immunological mechanisms in vitro and in vivo. A number of studies have investigated their effects on cellular and innate immunity, and their clinical efficacy, but there is no consensus as to their real usefulness. The main aim of this review is to analyse the available data concerning the activity and efficacy of immunostimulants in preventing pediatric RRTIs. The majority of studies have shown that the number of infections decreases after immunostimulant treatment, but they are affected by various methodological weaknesses. Further studies are urgently needed to confirm whether, when and which immunostimulants should be used.

Original languageEnglish
Pages (from-to)627-636
Number of pages10
JournalJournal of Biological Regulators and Homeostatic Agents
Volume27
Issue number3
Publication statusPublished - 2013

Fingerprint

Immunologic Adjuvants
Respiratory Tract Infections
Innate Immunity
Cellular Immunity
Quality of Life
Pediatrics
Anti-Bacterial Agents
Costs and Cost Analysis
Therapeutics
Infection

Keywords

  • Immucytal
  • Immunostimulants
  • OM-85 BV
  • Pidotimod
  • Prevention
  • Recurrent respiratory tract infections

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Cancer Research
  • Immunology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Immunostimulants and prevention of recurrent respiratory respiratory tract infections. / Esposito, Susanna; Musio, A.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 27, No. 3, 2013, p. 627-636.

Research output: Contribution to journalArticle

@article{7241382618924b9abd5a14404d4d9289,
title = "Immunostimulants and prevention of recurrent respiratory respiratory tract infections",
abstract = "Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for pediatricians. They affect the children's quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have been developed. One of the most widely used is the administration of immunostimulants: i.e. molecules of bacterial or synthetic origin that interact with immunological mechanisms in vitro and in vivo. A number of studies have investigated their effects on cellular and innate immunity, and their clinical efficacy, but there is no consensus as to their real usefulness. The main aim of this review is to analyse the available data concerning the activity and efficacy of immunostimulants in preventing pediatric RRTIs. The majority of studies have shown that the number of infections decreases after immunostimulant treatment, but they are affected by various methodological weaknesses. Further studies are urgently needed to confirm whether, when and which immunostimulants should be used.",
keywords = "Immucytal, Immunostimulants, OM-85 BV, Pidotimod, Prevention, Recurrent respiratory tract infections",
author = "Susanna Esposito and A. Musio",
year = "2013",
language = "English",
volume = "27",
pages = "627--636",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "3",

}

TY - JOUR

T1 - Immunostimulants and prevention of recurrent respiratory respiratory tract infections

AU - Esposito, Susanna

AU - Musio, A.

PY - 2013

Y1 - 2013

N2 - Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for pediatricians. They affect the children's quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have been developed. One of the most widely used is the administration of immunostimulants: i.e. molecules of bacterial or synthetic origin that interact with immunological mechanisms in vitro and in vivo. A number of studies have investigated their effects on cellular and innate immunity, and their clinical efficacy, but there is no consensus as to their real usefulness. The main aim of this review is to analyse the available data concerning the activity and efficacy of immunostimulants in preventing pediatric RRTIs. The majority of studies have shown that the number of infections decreases after immunostimulant treatment, but they are affected by various methodological weaknesses. Further studies are urgently needed to confirm whether, when and which immunostimulants should be used.

AB - Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for pediatricians. They affect the children's quality of life, cause absences from school and lost parental working days, and repeated medical examinations, hospital admissions as well as antibiotic therapies lead to high costs for society. Given their prevalence and clinical importance, various prevention strategies have been developed. One of the most widely used is the administration of immunostimulants: i.e. molecules of bacterial or synthetic origin that interact with immunological mechanisms in vitro and in vivo. A number of studies have investigated their effects on cellular and innate immunity, and their clinical efficacy, but there is no consensus as to their real usefulness. The main aim of this review is to analyse the available data concerning the activity and efficacy of immunostimulants in preventing pediatric RRTIs. The majority of studies have shown that the number of infections decreases after immunostimulant treatment, but they are affected by various methodological weaknesses. Further studies are urgently needed to confirm whether, when and which immunostimulants should be used.

KW - Immucytal

KW - Immunostimulants

KW - OM-85 BV

KW - Pidotimod

KW - Prevention

KW - Recurrent respiratory tract infections

UR - http://www.scopus.com/inward/record.url?scp=84891588635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891588635&partnerID=8YFLogxK

M3 - Article

C2 - 24152832

AN - SCOPUS:84891588635

VL - 27

SP - 627

EP - 636

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 3

ER -